Featured Research

from universities, journals, and other organizations

Protein keeps sleep-deprived flies ready to learn

Date:
May 8, 2011
Source:
Washington University School of Medicine
Summary:
A protein that helps the brain develop early in life can fight the mental fuzziness induced by sleep deprivation, according to researchers.

A protein that helps the brain develop early in life can fight the mental fuzziness induced by sleep deprivation, according to researchers at Washington University School of Medicine in St. Louis.

"It's interesting that NOTCH, a protein that plays such a prominent role in development, also has important functions in the adult brain," says senior author Paul Shaw, PhD, associate professor of neurobiology. "To our surprise, we found if NOTCH activity is boosted in the brains of sleep-deprived fruit flies, the flies can continue to stay sharp and learn after sleep deprivation. They behave as if they had a full night's sleep."

Shaw studies interactions between sleep and learning to develop treatments that help the brain resist the mental impairments imposed by sleep deprivation. He wants to assist people forced to work with minimal sleep, such as members of the military or disaster relief workers.

The findings appear online May 5 in Current Biology.

Shaw and his colleagues test flies' ability to learn by pairing a negative stimulus (the chemical quinine, which flies prefer to avoid) with a positive stimulus (a light, which flies instinctively seek). When offered an opportunity to enter a darkened tube or a lighted tube with quinine, flies that can learn suppress their natural desire to choose the light. Flies, like humans, show a progressive decline in cognitive performance during the course of a typical waking day. Prolonged disruption of sleep causes a much sharper drop in learning.

Shaw became interested in NOTCH when his group found that sleep deprivation in flies caused increased activity in a gene that suppresses NOTCH. They found a similar increase in humans following sleep loss. They went on to show that when that suppressor is genetically disabled, allowing increased NOTCH activity, flies continue to learn even when sleep-deprived.

To further confirm NOTCH's involvement in these processes, Shaw and lead author Laurent Seugnet, PhD, a researcher now at the Lyon Neuroscience Research Center in Lyon, France, analyzed where NOTCH is made in the brain. They found that in adult fruit flies, specialized brain cells known as glia make NOTCH. Scientists have typically regarded glia as passive support cells that merely nourish and supply neurons, the cells that do the "work" of the brain. According to Shaw, though, this study and others have scientists reconsidering how actively glia may be involved in certain mental processes, including sleep.

"We may want to target glia to reduce or slow the cognitive deficits associated with increased wakefulness, allowing people such as emergency personnel and air traffic controllers to stay awake and functional for extended periods of time," Shaw says. "If modifying glia can slow negative outcomes associated with prolonged wakefulness, that may provide us with a more natural way of helping people stay awake than directly targeting neurons."

Seugnet L, Suzuki Y, Merlin G, Gottschalk L, Duntley SP, Shaw PJ. Notch signaling modulates sleep homeostasis and learning after sleep deprivation in Drosophila. Current Biology, May 5, 2011.

Funding from the McDonnell Center for Cellular and Molecular Neurobiology and the National Institutes of Health (NIH) Neuroscience Blueprint Core Grant supported this research.


Story Source:

The above story is based on materials provided by Washington University School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Laurent Seugnet, Yasuko Suzuki, Gabriel Merlin, Laura Gottschalk, Stephen P. Duntley, Paul J. Shaw. Notch signaling modulates sleep homeostasis and learning after sleep deprivation in Drosophila. Current Biology, May 5, 2011 DOI: 10.1016/j.cub.2011.04.001

Cite This Page:

Washington University School of Medicine. "Protein keeps sleep-deprived flies ready to learn." ScienceDaily. ScienceDaily, 8 May 2011. <www.sciencedaily.com/releases/2011/05/110505123952.htm>.
Washington University School of Medicine. (2011, May 8). Protein keeps sleep-deprived flies ready to learn. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/05/110505123952.htm
Washington University School of Medicine. "Protein keeps sleep-deprived flies ready to learn." ScienceDaily. www.sciencedaily.com/releases/2011/05/110505123952.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins